, V?24J?18 + dot plot defined the iNKT cells. (B) Comparative analysis of iNKT cells among the TB/HIV (n = 33), HIV (n = 25), TB (n = 27), and HC (n = 25) groups, before any therapeutic intervention, based on the CD3 + CD56 + V?24J?18 + or CD3 + V?24J?18 + populations. REFERENCES 1. WHO. Global Tuberculosis Report, vol.69, 2018.
, Available online at, WHO Fact Sheets on TB, vol.16, 2018.
, Available online at, Boletim, 2008.
, Panorama Epidemiológico E Atividades Colaborativas, 2017.
Management of individuals requiring antiretroviral therapy and TB treatment, Curr Opin HIV AIDS, vol.5, pp.61-70, 2010. ,
Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective obse, Lancet Infect Dis, vol.15, pp.429-467, 2015. ,
TB-IRIS Study Group. Clinical spectrum, risk factors and outcome of immune reconstitution inflammatory syndrome in patients with tuberculosis-HIV coinfection, Antivir Ther, vol.17, pp.841-849, 2012. ,
The Immunopathogenesis of the HIV tuberculosis immune reconstitution inflammatory syndrome, Eur J Immunol, vol.43, pp.1995-2002, 2013. ,
Tuberculosis immune reconstitution inflammatory syndrome in A5221 STRIDE: timing, severity, and implications for HIV-TB programs, J Acquir Immune Defic Syndr, vol.65, pp.423-431, 2014. ,
Immune reconstitution inflammatory syndrome in HIV-infected patients, HIV/AIDS, vol.7, pp.49-64, 2015. ,
The tuberculosisassociated immune reconstitution inflammatory syndrome: recent advances in clinical and pathogenesis research, Curr Opin HIV AIDS, vol.13, pp.512-533, 2018. ,
Immune reconstitution syndrome in tuberculosis and HIV-co-infected patients: Th1 explosion or cytokine storm? AIDS, vol.21, pp.882-886, 2007. ,
Corticosteroid therapy, vitamin D status, and inflammatory cytokine profile in the HIV-tuberculosis immune reconstitution inflammatory syndrome, Clin Infect Dis, vol.55, pp.1004-1015, 2012. ,
Role of IL-6 in Mycobacterium avium-associated immune reconstitution inflammatory syndrome, J Immunol, vol.192, pp.676-82, 2013. ,
Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients, AIDS, vol.20, pp.1-7, 2006. ,
Tuberculosis-associated immune restoration syndrome in HIV-1-infected patients involves tuberculin-specific CD4 Th1 cells and KIR-negative T cells, J Immunol, vol.183, pp.3915-3938, 2009. ,
Type 1 helper T cells and FoxP3-positive T cells in HIVtuberculosis-associated immune reconstitution inflammatory syndrome, Am J Respir Crit Care Med, vol.178, pp.1083-1092, 2008. ,
Risk factors for increased immune reconstitution in response to Mycobacterium tuberculosis antigens in tuberculosis HIVinfected, antiretroviral-naïve patients, BMC Infect Dis, vol.17, p.606, 2017. ,
Natural killer cell activation distinguishes Mycobacterium tuberculosismediated immune reconstitution syndrome from chronic HIV and HIV/MTB coinfection, J Acquir Immune Defic Syndr, vol.58, pp.309-327, 2011. ,
Natural killer cell degranulation capacity predicts early onset of the immune reconstitution inflammatory syndrome (IRIS) in HIV-infected patients with tuberculosis, Blood, vol.119, pp.3315-3335, 2012. ,
Mycobacterial antigen driven activation of CD14++CD16-monocytes is a predictor of tuberculosis-associated immune reconstitution inflammatory syndrome, PLoS Pathog, vol.10, p.1004433, 2014. ,
HIV-Tuberculosis-associated immune reconstitution inflammatory syndrome is characterized by toll-like receptor and inflammasome signalling, Nat Commun, vol.6, p.8451, 2015. ,
Plasma interleukin-18 levels are a biomarker of innate immune responses that predict and characterize tuberculosis-associated immune reconstitution inflammatory syndrome, AIDS, vol.29, pp.421-452, 2015. ,
aberrant inflammasome activation characterizes tuberculosisassociated immune reconstitution inflammatory syndrome, J Immunol, vol.196, pp.4052-63, 2016. ,
Neutrophil activation and enhanced release of granule products in HIV-TB immune reconstitution inflammatory syndrome, J Acquir Immune Defic Syndr, vol.77, pp.221-230, 2018. ,
HIV-associated tuberculosis in developing countries: clinical features, diagnosis, and treatment, Bull World Health Organ, vol.70, pp.515-541, 1992. ,
T cell activation and cytokine profile of tuberculosis and HIV-positive individuals during antituberculous treatment and efavirenzbased regimens, PLoS ONE, vol.8, 2013. ,
, Available online at, Tuberculosis Fact Sheet, 2015.
The mechanisms and consequences of the extra-pulmonary dissemination of Mycobacterium tuberculosis, Tuberculosis, vol.90, pp.361-367, 2010. ,
Site of extrapulmonary tuberculosis is associated with HIV infection, Clin Infect Dis, vol.55, pp.75-81, 2012. ,
Extrapulmonary tuberculosis: update on the epidemiology, risk factors and prevention strategies, Int J Trop Dis, vol.1, p.6, 2018. ,
Extra Pulmonary Tuberculosis: An Overview, Role of Microbes in Human Health and Diseases, Nar Singh Chauhan. IntechOpen, 2018. ,
The bacterial and host factors associated with extrapulmonary dissemination of Mycobacterium tuberculosis, Front Biol, vol.10, pp.252-61, 2015. ,
Protocolo Clínico E Diretrizes Terapêuticas Para O Manejo Da Infecção Pelo HIV Em Adultos, 2018. ,
Comitê Técnico Assessor do Programa Nacional de Controle da Tuberculos. Manual de Recomendações para o Controle da Tuberculose no Brasil. Ministério da Saúde, Secretaria de Vigilância em Saúde, Departamento de Vigilância Epidemiológica, 284p. Available online at, 2011. ,
Predictors of early mortality and effectiveness of antiretroviral therapy in TB-HIV patients from Brazil, PLoS ONE, vol.14, 2019. ,
Immune reconstitution syndrome in HIV: validating a case definition and identifying clinical predictors in persons initiating antiretroviral therapy, Clin Infect Dis, vol.42, pp.1639-1685, 2006. ,
Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings, Lancet Infect Dis, vol.8, pp.516-539, 2008. ,
Characterization of human invariant natural killer t subsets in health and disease using a novel invariant natural killer T cellclonotypic monoclonal antibody, 6B11. Immunology, vol.122, pp.1-14, 2007. ,
Selective activation, expansion, and monitoring of human iNKT cells with a monoclonal antibody specific for the TCR alpha-chain CDR3 loop, Eur J Immunol, vol.38, pp.1756-66, 2008. ,
Comparison of 6B11 mAb and ?-GalCer-loaded CD1d dextramers for detection of iNKT cells by flow cytometry, J Immunol Methods, vol.446, pp.1-6, 2017. ,
CD107a as a functional marker for the identification of natural killer cell activity, J Immunol Methods, vol.294, pp.15-22, 2004. ,
Highly accurate sigmoidal fitting of real-time PCR data by introducing a parameter for asymmetry, BMC Bioinformatics, vol.9, p.221, 2008. ,
Immune Reconstitution syndrome in patients treated for HIV and tuberculosis in Rio de Janeiro, Braz J Infect Dis, vol.11, pp.462-467, 2007. ,
Management of HIV-associated tuberculosis in resource-limited settings: a state-of-the-art review, BMC Med, vol.11, p.253, 2013. ,
Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates, Proc Natl Acad Sci, vol.100, pp.15011-15017, 2003. ,
Alterations in natural killer cell receptor profiles during HIV type 1 disease progression among chronically infected South African adults, AIDS Res Hum Retroviruses, vol.26, pp.4611-4618, 2005. ,
Study of KIR genes in tuberculosis patients, Tissue Antigens, vol.68, p.386389, 2006. ,
Functionally relevant decreases in activatory receptor expression on NK cells are associated with pulmonary tuberculosis in vivo and persist after successful treatment, Int Immunol, vol.21, pp.779-91, 2009. ,
Killer cell immunoglobulin like receptor gene association with tuberculosis, Hum Immunol, vol.74, pp.85-92, 2013. ,
Earlier versus later start of antiretroviral therapy in HIV-infected adults with uberculosis, N Engl J Med, vol.365, pp.1471-81, 2011. ,
The effect of early initiation of antiretroviral therapy in TB/HIV-coinfected patients: a systematic review and meta-analysis, J Int Assoc Provid AIDS Care, vol.14, pp.560-70, 2105. ,
Immune reconstitution inflammatory syndrome: risk factors and treatment implications, J Acquir Immune Defic Syndr, vol.46, pp.456-62, 2007. ,
Risk factor analyses for immune reconstitution inflammatory syndrome in a randomized study of early vs. deferred ART during an Opportunistic Infection, PLoS ONE, vol.5, 2010. ,
TLR2-induced cytokine responses may characterize HIV-infected patients experiencing mycobacterial immune restoration disease, AIDS, vol.25, 2011. ,
NKp80 defines a critical step during human natural killer cell development, Cell Rep, vol.16, pp.379-91, 2016. ,
Expansion of CD94/NKG2C NK cells in response to human cytomegalovirus-infected fibroblasts, Blood, vol.107, pp.3624-3655, 2006. ,
Coordinated expansion of both memory T cells and NK cells in response to CMV infection in humans, Eur J Immunol, vol.46, pp.1168-79, 2016. ,
Human adaptive natural killer cells: beyond NKG2C, Trends Immunol, vol.37, pp.351-354, 2016. ,
Tracking KLRC2 (NKG2C)+ memory-like NK cells in SIV+ and rhCMV+ rhesus macaques, PLoS Pathog, vol.14, 2018. ,
Functional and phenotypic changes of natural killer cells in whole blood during Mycobacterium tuberculosis infection and disease, Front Immunol, vol.9, p.257, 2018. ,
The NKp46 receptor contributes to NK cell lysis of mononuclear phagocytes infected with an intracellular bacterium, J Immunol, vol.168, pp.3451-3458, 2014. ,
Human NK cell education by inhibitory receptors for MHC class I, Immunity, vol.25, pp.331-373, 2006. ,
URL : https://hal.archives-ouvertes.fr/hal-00165596
Beyond licensing and disarming: a quantitative view on NK-cell education, Eur J Immunol, vol.38, pp.2934-2941, 2008. ,
Potential role of V?2+ ??T cells in regulation of immune activation in primary HIV infection. Front Immunol, vol.8, p.1189, 2017. ,
Protective immune responses of major V?2V?2 T-cell subset in M. tuberculosis infection, Curr Opin Immunol, vol.42, pp.105-117, 2016. ,
Activation of ?? T cells in the primary immune response to Mycobacterium tuberculosis, Science, vol.244, pp.713-719, 1989. ,
Mucosal-associated invariant and ?? T cell subsets respond to initial Mycobacterium tuberculosis infection, JCI Insight, vol.3, p.121899, 2018. ,
Adoptive transfer of phosphoantigen-specific ?? T cell subset attenuates Mycobacterium tuberculosis infection in nonhuman primates, J Immunol, vol.198, pp.4753-63, 2017. ,
Presumed guilty: natural killer T cell defects and human disease, Nat Rev Immunol, vol.11, pp.131-173, 2011. ,
Invariant NKT cells from HIV-1 or Mycobacterium tuberculosis-infected patients express an activated phenotype, Clin Immunol, vol.127, pp.1-6, 2008. ,
Invariant natural killer T cell dynamics in HIV-associated tuberculosis, Clin Infect Dis, 2019. ,
Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8-alpha/beta T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain, J Exp Med, vol.178, pp.1-16, 1993. ,
An invariant V alpha 24-J alpha Q/V beta 11 T cell receptor is expressed in all individuals by clonally expanded CD4-8-T cells, J Exp Med, vol.180, pp.1171-1177, 1994. ,
NKT cells: facts, functions and fallacies, Immunol Today, vol.21, pp.573-83, 2000. ,
Comparison of two flow cytometric methods for detection of human invariant natural killer Q18 T cells (iNKT), Iran J Immunol, vol.7, pp.1-7, 2010. ,
Lymphokine-activated killer cells, natural killer cells and cytokines, Curr Opin Immunol, vol.3, pp.49-55, 1991. ,
Natural killer cell-mediated cytokine response among HIV-positive south Indians with pulmonary tuberculosis, J Interferon Cytokine Res, vol.30, pp.33-42, 2010. ,
Persistence of pathological distribution of NK cells in HIV-infected patients with prolonged use of HAART and a sustained immune response, PLoS ONE, vol.10, p.121019, 2015. ,
Natural killer cells in HIV-1 infection and therapy, AIDS, vol.31, pp.2317-2347, 2017. ,
CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC, Eur J Immunol, vol.40, pp.2174-81, 2010. ,
CD161 defines a functionally distinct subset of pro-inflammatory natural killer cells, Front Immunol, vol.9, p.486, 2018. ,
Normalization of natural killer cell function and phenotype with effective anti-HIV therapy and the role of IL-10, AIDS, vol.16, pp.1251-1257, 2002. ,
, HIV/AIDS, 2018.